| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 24 | 2013 | 436 | 1.690 |
Why?
|
| Lung | 14 | 2011 | 606 | 0.830 |
Why?
|
| Lung Diseases | 6 | 2016 | 126 | 0.800 |
Why?
|
| Adenocarcinoma | 11 | 2012 | 329 | 0.760 |
Why?
|
| Mesothelioma | 7 | 2012 | 25 | 0.650 |
Why?
|
| Bronchioles | 1 | 2015 | 2 | 0.580 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 32 | 0.550 |
Why?
|
| Precancerous Conditions | 4 | 2003 | 68 | 0.550 |
Why?
|
| Adenoma | 2 | 2013 | 54 | 0.530 |
Why?
|
| Bronchi | 4 | 2006 | 66 | 0.510 |
Why?
|
| Biomarkers, Tumor | 7 | 2013 | 423 | 0.510 |
Why?
|
| Pathology, Surgical | 1 | 2013 | 11 | 0.500 |
Why?
|
| Carcinoid Tumor | 2 | 2011 | 15 | 0.480 |
Why?
|
| Alveolitis, Extrinsic Allergic | 2 | 2011 | 6 | 0.450 |
Why?
|
| Schools, Medical | 1 | 2013 | 136 | 0.450 |
Why?
|
| Diagnosis, Differential | 11 | 2013 | 750 | 0.450 |
Why?
|
| Prototheca | 1 | 2011 | 1 | 0.440 |
Why?
|
| Eye Infections | 1 | 2011 | 1 | 0.440 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2011 | 1 | 0.440 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2011 | 3 | 0.440 |
Why?
|
| Cough | 2 | 2006 | 160 | 0.430 |
Why?
|
| Pleural Neoplasms | 6 | 2012 | 16 | 0.430 |
Why?
|
| Faculty, Medical | 1 | 2013 | 175 | 0.420 |
Why?
|
| Surgical Wound Infection | 1 | 2011 | 74 | 0.420 |
Why?
|
| Neuroendocrine Tumors | 1 | 2011 | 22 | 0.420 |
Why?
|
| Histiocytosis, Langerhans-Cell | 3 | 2016 | 16 | 0.380 |
Why?
|
| Pleura | 3 | 2011 | 10 | 0.330 |
Why?
|
| Humans | 53 | 2016 | 49600 | 0.330 |
Why?
|
| Arteriovenous Malformations | 1 | 2007 | 21 | 0.320 |
Why?
|
| Eosinophilia | 1 | 2007 | 23 | 0.320 |
Why?
|
| Eosinophils | 1 | 2007 | 42 | 0.320 |
Why?
|
| Pneumothorax | 1 | 2007 | 31 | 0.320 |
Why?
|
| Pulmonary Artery | 1 | 2007 | 68 | 0.310 |
Why?
|
| Pulmonary Alveoli | 3 | 1997 | 36 | 0.310 |
Why?
|
| Diagnostic Errors | 1 | 2007 | 85 | 0.310 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 1997 | 103 | 0.300 |
Why?
|
| Immunohistochemistry | 9 | 2016 | 811 | 0.280 |
Why?
|
| Neoplasm Proteins | 3 | 2007 | 256 | 0.280 |
Why?
|
| Bronchoscopy | 3 | 2014 | 43 | 0.280 |
Why?
|
| Chondromatosis, Synovial | 1 | 2004 | 2 | 0.270 |
Why?
|
| Knee | 1 | 2004 | 21 | 0.270 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2004 | 12 | 0.260 |
Why?
|
| Carcinoma, Small Cell | 5 | 2011 | 16 | 0.250 |
Why?
|
| Epithelium | 5 | 2011 | 97 | 0.250 |
Why?
|
| ErbB Receptors | 1 | 2004 | 98 | 0.250 |
Why?
|
| Male | 28 | 2016 | 23124 | 0.240 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 3 | 2003 | 5 | 0.240 |
Why?
|
| Middle Aged | 23 | 2016 | 13449 | 0.230 |
Why?
|
| Hyperplasia | 7 | 2011 | 82 | 0.220 |
Why?
|
| Biopsy | 5 | 1999 | 326 | 0.210 |
Why?
|
| Adenomatosis, Pulmonary | 1 | 2001 | 1 | 0.210 |
Why?
|
| Fibrosis | 3 | 2015 | 97 | 0.210 |
Why?
|
| RNA-Binding Proteins | 3 | 2011 | 364 | 0.210 |
Why?
|
| Reflex | 1 | 2000 | 25 | 0.200 |
Why?
|
| Peritoneal Neoplasms | 2 | 2011 | 19 | 0.190 |
Why?
|
| Female | 30 | 2016 | 26316 | 0.190 |
Why?
|
| Gastroesophageal Reflux | 1 | 2000 | 60 | 0.190 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1998 | 11 | 0.180 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1998 | 12 | 0.180 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1998 | 47 | 0.180 |
Why?
|
| Prognosis | 9 | 2006 | 1250 | 0.160 |
Why?
|
| Cathepsin B | 1 | 1997 | 13 | 0.160 |
Why?
|
| Zeolites | 1 | 1997 | 2 | 0.160 |
Why?
|
| Laminin | 1 | 1997 | 74 | 0.160 |
Why?
|
| Pneumocystis | 1 | 1996 | 3 | 0.160 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1996 | 14 | 0.150 |
Why?
|
| Benzenesulfonates | 1 | 1996 | 15 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 1996 | 84 | 0.150 |
Why?
|
| Lymphatic Diseases | 1 | 1995 | 11 | 0.150 |
Why?
|
| Mediastinal Diseases | 1 | 1995 | 12 | 0.150 |
Why?
|
| Aged | 15 | 2016 | 10872 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 5 | 2011 | 141 | 0.140 |
Why?
|
| Fluorescent Dyes | 1 | 1996 | 186 | 0.130 |
Why?
|
| Inflammation | 4 | 2015 | 978 | 0.130 |
Why?
|
| Glass | 1 | 1994 | 21 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 190 | 0.130 |
Why?
|
| Adult | 15 | 2016 | 13326 | 0.130 |
Why?
|
| Neoplasm Staging | 8 | 1997 | 372 | 0.130 |
Why?
|
| Herpes Simplex | 1 | 2014 | 32 | 0.130 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1993 | 28 | 0.120 |
Why?
|
| Aged, 80 and over | 7 | 2007 | 4222 | 0.120 |
Why?
|
| Genital Neoplasms, Female | 1 | 1993 | 24 | 0.120 |
Why?
|
| Adolescent | 7 | 2016 | 5317 | 0.120 |
Why?
|
| Thoracotomy | 1 | 2013 | 30 | 0.120 |
Why?
|
| Bronchitis | 2 | 2006 | 23 | 0.120 |
Why?
|
| Carcinoma | 1 | 1993 | 112 | 0.120 |
Why?
|
| Smoking | 4 | 2016 | 741 | 0.110 |
Why?
|
| Carcinoma in Situ | 2 | 2006 | 33 | 0.110 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2011 | 11 | 0.110 |
Why?
|
| Visual Acuity | 1 | 2011 | 78 | 0.110 |
Why?
|
| Antifungal Agents | 1 | 2011 | 96 | 0.100 |
Why?
|
| Reoperation | 1 | 2011 | 177 | 0.100 |
Why?
|
| Pneumonia, Viral | 1 | 2014 | 186 | 0.100 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2006 | 151 | 0.100 |
Why?
|
| Ethanolamines | 1 | 2009 | 20 | 0.100 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 1 | 2009 | 18 | 0.090 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2009 | 29 | 0.090 |
Why?
|
| Viral Fusion Proteins | 1 | 2009 | 69 | 0.090 |
Why?
|
| Newcastle disease virus | 1 | 2009 | 83 | 0.090 |
Why?
|
| Virion | 1 | 2009 | 113 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2009 | 1781 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2007 | 281 | 0.080 |
Why?
|
| Pneumonia | 2 | 2003 | 233 | 0.080 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2007 | 13 | 0.080 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2007 | 18 | 0.080 |
Why?
|
| Child | 4 | 2011 | 3783 | 0.080 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2007 | 11 | 0.080 |
Why?
|
| Antibodies, Viral | 1 | 2009 | 319 | 0.080 |
Why?
|
| Young Adult | 2 | 2016 | 3698 | 0.080 |
Why?
|
| Massachusetts | 1 | 2013 | 2017 | 0.080 |
Why?
|
| Endometrial Neoplasms | 1 | 2007 | 47 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 50 | 0.080 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2006 | 14 | 0.080 |
Why?
|
| HIV Infections | 1 | 1993 | 898 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 602 | 0.070 |
Why?
|
| Calcium | 1 | 2009 | 518 | 0.070 |
Why?
|
| Rats, Inbred F344 | 2 | 1997 | 55 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2006 | 2520 | 0.070 |
Why?
|
| Foreign-Body Reaction | 2 | 1997 | 14 | 0.070 |
Why?
|
| Immunoenzyme Techniques | 3 | 2006 | 99 | 0.070 |
Why?
|
| Teratoma | 1 | 2005 | 12 | 0.070 |
Why?
|
| DNA, Neoplasm | 2 | 2003 | 47 | 0.070 |
Why?
|
| Osteochondroma | 1 | 2004 | 3 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 1993 | 1036 | 0.070 |
Why?
|
| Rats | 3 | 1998 | 1680 | 0.060 |
Why?
|
| Animals | 8 | 2009 | 17698 | 0.060 |
Why?
|
| Mycobacterium avium Complex | 1 | 2003 | 3 | 0.060 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2003 | 8 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2005 | 1706 | 0.060 |
Why?
|
| Respiratory Tract Infections | 1 | 2003 | 68 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2006 | 671 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2004 | 1376 | 0.060 |
Why?
|
| Immunity | 1 | 2003 | 95 | 0.060 |
Why?
|
| Viruses | 1 | 2003 | 80 | 0.060 |
Why?
|
| Biomarkers | 1 | 2007 | 1002 | 0.060 |
Why?
|
| Cell Division | 1 | 2004 | 398 | 0.060 |
Why?
|
| Virus Diseases | 1 | 2003 | 110 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2005 | 175 | 0.060 |
Why?
|
| Asthma | 1 | 2006 | 369 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 1142 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 1997 | 4513 | 0.050 |
Why?
|
| Textile Industry | 1 | 1999 | 5 | 0.050 |
Why?
|
| Bronchiolitis Obliterans | 1 | 1999 | 7 | 0.050 |
Why?
|
| Esophagus | 1 | 2000 | 41 | 0.050 |
Why?
|
| Pulmonary Fibrosis | 2 | 1997 | 24 | 0.050 |
Why?
|
| Struma Ovarii | 1 | 1999 | 3 | 0.050 |
Why?
|
| Thyrotoxicosis | 1 | 1999 | 7 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2006 | 2121 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 456 | 0.050 |
Why?
|
| Frozen Sections | 1 | 1998 | 11 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 1999 | 110 | 0.040 |
Why?
|
| Tracheitis | 1 | 1997 | 1 | 0.040 |
Why?
|
| Paraneoplastic Syndromes | 1 | 1997 | 6 | 0.040 |
Why?
|
| Airway Obstruction | 1 | 1997 | 14 | 0.040 |
Why?
|
| Pemphigus | 1 | 1997 | 14 | 0.040 |
Why?
|
| Fluorocarbons | 1 | 1998 | 23 | 0.040 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 1998 | 27 | 0.040 |
Why?
|
| Mice | 3 | 2009 | 9076 | 0.040 |
Why?
|
| Pleurisy | 1 | 1997 | 1 | 0.040 |
Why?
|
| Nevada | 1 | 1997 | 3 | 0.040 |
Why?
|
| Pleural Diseases | 1 | 1997 | 7 | 0.040 |
Why?
|
| Oregon | 1 | 1997 | 19 | 0.040 |
Why?
|
| Chemistry, Physical | 1 | 1997 | 44 | 0.040 |
Why?
|
| Occupational Diseases | 1 | 1999 | 240 | 0.040 |
Why?
|
| Carcinogens | 1 | 1997 | 35 | 0.040 |
Why?
|
| Receptor, ErbB-2 | 1 | 1997 | 48 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 1997 | 30 | 0.040 |
Why?
|
| Chemical Phenomena | 1 | 1997 | 89 | 0.040 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 1996 | 2 | 0.040 |
Why?
|
| Silver Staining | 1 | 1996 | 5 | 0.040 |
Why?
|
| Tissue Fixation | 1 | 1996 | 19 | 0.040 |
Why?
|
| Paraffin Embedding | 1 | 1996 | 13 | 0.040 |
Why?
|
| Microscopy | 1 | 1997 | 68 | 0.040 |
Why?
|
| Occupational Exposure | 1 | 1999 | 303 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2016 | 14 | 0.040 |
Why?
|
| Forecasting | 1 | 1997 | 193 | 0.040 |
Why?
|
| Tumor Virus Infections | 1 | 1996 | 40 | 0.040 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1996 | 58 | 0.040 |
Why?
|
| Herpesviridae Infections | 1 | 1996 | 32 | 0.040 |
Why?
|
| Germinoma | 1 | 1995 | 2 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 1997 | 182 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1996 | 69 | 0.040 |
Why?
|
| Carcinoma, Papillary | 1 | 1996 | 34 | 0.040 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2016 | 50 | 0.040 |
Why?
|
| ras Proteins | 1 | 2016 | 70 | 0.040 |
Why?
|
| Testicular Neoplasms | 1 | 1995 | 25 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1995 | 28 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 179 | 0.040 |
Why?
|
| Heart Neoplasms | 1 | 1995 | 29 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 1998 | 218 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 187 | 0.040 |
Why?
|
| Thyroid Neoplasms | 1 | 1996 | 67 | 0.040 |
Why?
|
| Survival Rate | 1 | 1997 | 656 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 1994 | 24 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 1996 | 169 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 249 | 0.030 |
Why?
|
| Lipoma | 1 | 1994 | 16 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 1997 | 1936 | 0.030 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1994 | 34 | 0.030 |
Why?
|
| Acyclovir | 1 | 2014 | 20 | 0.030 |
Why?
|
| Survival Analysis | 2 | 1992 | 473 | 0.030 |
Why?
|
| Vulvar Neoplasms | 1 | 1993 | 9 | 0.030 |
Why?
|
| Cocaine | 1 | 1994 | 74 | 0.030 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1993 | 25 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 3 | 2003 | 199 | 0.030 |
Why?
|
| Cell Line | 2 | 2009 | 1921 | 0.030 |
Why?
|
| Peritoneum | 1 | 2011 | 30 | 0.030 |
Why?
|
| Lymphocytes | 2 | 2003 | 170 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2014 | 291 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 1991 | 187 | 0.020 |
Why?
|
| Oscillometry | 1 | 2009 | 11 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2009 | 15 | 0.020 |
Why?
|
| Formoterol Fumarate | 1 | 2009 | 5 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2009 | 28 | 0.020 |
Why?
|
| Histamine | 1 | 2009 | 39 | 0.020 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2009 | 20 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1995 | 1049 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 1989 | 55 | 0.020 |
Why?
|
| HN Protein | 1 | 2009 | 56 | 0.020 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2009 | 48 | 0.020 |
Why?
|
| Immunization | 1 | 2009 | 115 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 57 | 0.020 |
Why?
|
| Bronchodilator Agents | 1 | 2009 | 52 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2009 | 84 | 0.020 |
Why?
|
| Necrosis | 3 | 1997 | 115 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1992 | 559 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2009 | 160 | 0.020 |
Why?
|
| Infant | 2 | 1994 | 1387 | 0.020 |
Why?
|
| Mutation | 1 | 2016 | 2187 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2009 | 150 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 453 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2009 | 814 | 0.020 |
Why?
|
| Global Health | 1 | 1988 | 136 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 34 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 1994 | 606 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 884 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2007 | 122 | 0.020 |
Why?
|
| Cervix Uteri | 1 | 2006 | 56 | 0.020 |
Why?
|
| Sex Factors | 1 | 1987 | 851 | 0.020 |
Why?
|
| Gene Expression | 1 | 2007 | 753 | 0.020 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2003 | 1 | 0.020 |
Why?
|
| Hybridization, Genetic | 1 | 2003 | 12 | 0.020 |
Why?
|
| Genes, Viral | 1 | 2003 | 55 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2003 | 33 | 0.020 |
Why?
|
| Vero Cells | 1 | 2003 | 78 | 0.020 |
Why?
|
| Vaccinia | 1 | 2003 | 40 | 0.020 |
Why?
|
| Immunocompetence | 1 | 2003 | 20 | 0.020 |
Why?
|
| Age Factors | 1 | 1987 | 1410 | 0.020 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2003 | 71 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2005 | 387 | 0.020 |
Why?
|
| Allelic Imbalance | 1 | 2002 | 7 | 0.010 |
Why?
|
| Gene Amplification | 1 | 2002 | 22 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 2002 | 32 | 0.010 |
Why?
|
| Radiography | 1 | 2003 | 341 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2002 | 60 | 0.010 |
Why?
|
| Nylons | 1 | 1999 | 7 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1999 | 47 | 0.010 |
Why?
|
| Thyroglobulin | 1 | 1999 | 10 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1999 | 27 | 0.010 |
Why?
|
| Cytokines | 1 | 2003 | 816 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1999 | 96 | 0.010 |
Why?
|
| Air Pollutants, Occupational | 1 | 1999 | 76 | 0.010 |
Why?
|
| Penicillin G | 1 | 1998 | 6 | 0.010 |
Why?
|
| Macrophages | 1 | 2003 | 913 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1997 | 46 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 166 | 0.010 |
Why?
|
| Hypoxia | 1 | 1997 | 73 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2003 | 2854 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 198 | 0.010 |
Why?
|
| Vena Cava, Inferior | 1 | 1995 | 26 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1995 | 299 | 0.010 |
Why?
|
| Skin | 1 | 1997 | 318 | 0.010 |
Why?
|
| Buttocks | 1 | 1994 | 9 | 0.010 |
Why?
|
| Lipomatosis | 1 | 1994 | 7 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1996 | 269 | 0.010 |
Why?
|
| Facial Dermatoses | 1 | 1994 | 12 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1995 | 166 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1994 | 61 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1994 | 229 | 0.010 |
Why?
|
| Survivors | 1 | 1992 | 139 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1992 | 527 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1989 | 236 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1989 | 123 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1988 | 58 | 0.010 |
Why?
|